Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 5, 2001, Pages 1367-1373

  Rothstein, D M ^a   Spacciapoli, P ^a   Tran, L T ^a   Xu, T ^a   Roberts, F D ^a   Dalla Serra, M ^a   Buxton, D K ^a   Oppenheim, F G ^a   Friden, P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTATIN; PEPTIDE;

AMIDATION; AMINO ACID SEQUENCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CARBOXY TERMINAL SEQUENCE; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; THRUSH;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SALIVARY PROTEINS; SARALASIN; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0035032562     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.5.1367-1373.2001     Document Type: Article

References (50)

1. Salivary histatins in patients with recurrent oral candidiasis
2. Mass spectrometry of peptides and proteins
3. Design of model amphipathic peptides having potent antimicrobial activities
4. Determination of the secondary structure of proteins from their circular dichroism spectra. I. Protein reference spectra for alpha-, beta- and irregular structures
5. Determinations of the helix and beta forms of proteins in aqueous solutions by circular dichroism
6. Antifungal peptides: Novel therapeutic compounds against emerging pathogens
7. Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesis
8. Three-dimensional structure of membrane and surface proteins
9. The hydrophobic moment detects periodicity in protein hydrophobicity
10. In vitro antimicrobial activity of MSI-78, a magainin analog
11. Antifungals: Mechanism of action and resistance, established and novel drugs
12. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis
13. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5
14. Peptide antibiotics
15. Cationic peptides: A new source of antibiotics
16. The role of antimicrobial peptides in animal defenses
17. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion
18. The effects of histatin-derived basic antimicrobial peptides on oral biofilms
19. Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides
20. Synthetic histatin analogues with broad-spectrum antimicrobial activity
21. Adsorption of human salivary proteins to hydroxyapatite: A comparison between whole saliva and glandular salivary secretions
22. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death
23. Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: Correlation with antifungal activity
24. Identification and characterization of the antimicrobial peptide corresponding to C-terminal beta-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor
25. Defensins: Antimicrobial and cytotoxic peptides of mammalian cells
26. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: Comparison with activity in serum
27. Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans
28. Longitudinal study of parotid saliva in HIV-1 infection
29. Clinical and microbial evaluation of a histatin containing mouthrinse in humans with experimental gingivitis
30. Inhibitory effects of human salivary histatins and lysozyme on coaggregation between Porphyromonas gingivalis and Streptococcus mitis
31. Inhibitory effects of synthetic histidine-rich peptides oń haemagglutination by Bacteroides gingivalis 381
32. Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis
33. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans
34. The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion
35. Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans
36. Determination of salivary anticandidal activities in healthy adults and patients with AIDS: A pilot study
37. Salivary histatin 5: Dependence of sequence, chain length, and helical conformation for candidacidal activity
38. Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins
39. Stabilization of helix by side-chain interactions in histatin-derived peptides: Role in candidacidal activity
40. Role of alphahelical conformation of histatin-5 in candidacidal activity examined by proline variants
41. Anti-lipopolysaccharide activity of histatins, peptides from human saliva
42. Evaluation of susceptibility of gram-positive and -negative bacteria to human defensins by using radial diffusion assay
43. Human salivary histatins: Promising antifungal therapeutic agents
44. Candidacidal activity of recombinant human salivary histatin-5 and variants
45. Membrane proteins: From sequence to structure
46. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
47. Salivary proteolysis of histidine-rich polypeptides and the antifungal activity of peptide degradation products
48. Anticandidal activity of major human salivary histatins
49. Salivary antimicrobials: Where are we?
50. Recombinant histatins: Functional domain duplication enhances candidacidal activity